ABO-Incompatible Kidney Transplantation Using Antigen-Specific Immunoadsorption and Rituximab

Abstract

We conclude that ABOi kidney transplantation using antigen-specific immunoadsorption and rituximab is equivalent to ABOc living donor kidney transplantation. ABOi transplantation after this protocol does not have a negative impact on long-term graft function.